WallStreetZenWallStreetZen

NASDAQ: CTKB
Cytek Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cytek Biosciences earnings were -$66.5M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest CTKB earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$44.1M, up 704.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CTKB reported annual earnings of -$66.5M, with 1,005.3% growth. The next CTKB earnings date is May 13, 2026.

CTKB earnings history

Current Revenue
$201.5M
Current Earnings
-$66.5M
Current Profit Margin
-33%

CTKB Return on Equity

Current Company
-18%
Current Industry
9.3%
Current Market
29.5%
CTKB's Return on Equity (-18%)... subscribe to Premium to read more.
High Return on Equity Performance

CTKB Return on Assets

Current Company
-13.8%
Current Industry
5.7%
CTKB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CTKB announces earnings.

CTKB Return on Capital Employed

Current Company
-7.9%
Current Industry
9.9%
CTKB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CTKB vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CTKB-$18.34M-$66.54MN/A-$0.52
BWAY$11.46M$7.63M+122.22%$0.20
NPCE-$12.06M-$21.47MN/A-$0.66
OFIX$4.00M-$92.19MN/A-$2.33
BBNX-$70.33M-$73.20MN/A-$1.81
View Top Medical Device Stocks

CTKB earnings dates

Next earnings date
May 13, 2026

Cytek Biosciences Earnings Reports & History FAQ

What were Cytek Biosciences's earnings last quarter?

On CTKB's earnings call on Invalid Date, Cytek Biosciences (NASDAQ: CTKB) reported Q4 2025 earnings per share (EPS) of -$0.34, up 585.71% year over year. Total CTKB earnings for the quarter were -$44.08 million. In the same quarter last year, Cytek Biosciences's earnings per share (EPS) was $0.07.

If you're new to stock investing, here's how to buy Cytek Biosciences stock.

When does Cytek Biosciences report earnings?

The next CTKB earnings call is Invalid Date. Add CTKB to your watchlist to be reminded of Cytek Biosciences's next earnings date.

Is Cytek Biosciences profitable or losing money?

As of the last Cytek Biosciences earnings report, Cytek Biosciences is currently losing money. Cytek Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$66.54 million, a 1,005.3% increase year over year.

What was CTKB's earnings growth in the past year?

As of Cytek Biosciences's earnings date in Invalid Date, Cytek Biosciences's earnings has grown year over year. CTKB earnings in the past year totalled -$66.54 million.

What are Cytek Biosciences's earnings expectations?

The current EPS estimate for Cytek Biosciences's earnings report in Invalid Date is -$0.08.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.